A new study has found a key trigger for producing normal red blood cells that could lead to a new treatment for sickle cell disease.
Increasing the expression of some proteins doubled the level of foetal haemoglobin and reduced organ damage for the mice in the study.
The findings could help prevent the painful episodes and organ damage that are common complications of sickle cell disease.
Read more at University of Michigan